| EVLA (Group 1, n = 149) | RFA (Group 2, n = 134) | P Value |
Operation Time (min) | 19.19 ± 5.44 | 19.71 ± 6.62 | NS |
GSV Length(cm) | 38.92 ± 6.88 | 41.83 ± 4.82 | P < 0.001 |
Tumescent (ml) | 343.18 ± 61.93 | 332.72 ± 70.11 | NS |
Hematoma n (%) | 2 (1.3%) | 1 (0.7%) | NS |
Ecchymosis n (%) | 13 (8.7%) | 8 (6%) | NS |
Edema n (%) | 21 (14.1%) | 12 (9%) | NS |
Paresthesia n (%) | 10 (6.7%) | 6 (4.5%) | NS |
Burn n (%) | 0 (0%) | 0 (0%) | NS |
DVT n (%) | 0 (0%) | 0 (0%) | NS |
PE n (%) | 0 (0%) | 0 (0%) | NS |
Phlebitis n (%) | 3 (2%) | 2 (1.5%) | NS |
Pain n (%) | 31 (20.8%) | 19 (14.2%) | NS |
VCSS |
|
|
|
Preoperative | 9.37 ± 0.99 | 8.91 ± 1.00 | P < 0.001 |
Postoperative 10th day | 4.56 ± 1.24 | 3.84 ± 1.11 | P < 0.001 |
Postoperative 1st month | 3.73 ± 1.37 | 3.69 ± 1.24 | NS |
Postoperative 3rd month | 2.84 ± 1.08 | 3.03 ± 1.13 | NS |
Postoperative 6th month | 1.83 ± 0.74 | 1.81 ± 0.74 | NS |
RDA | 2.10 ± 0.89 | 1.89 ± 0.89 | NS |
GSV Occlusion | 145 (96.6%) | 136 (98.5%) | NS |